Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356963 · ClinicalTrials.gov registry record · NA
Adjunct VR Pain Management in Acute Brain Injury
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04356963: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT04356963 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04356963, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. The investigators hypothesize that VR therapy will decrease pain and reduce opioid use in patients with acute traumatic injuries, including TBI.
Primary Outcome
Pre- vs. Post-Intervention Ratings on Numeric Pain Rating Scale. Numeric Pain Rating scale range is from 0 (no pain) -10 (severe pain)
Interventions
- BEHAVIORAL Virtual Reality Session (VR Blu)
- BEHAVIORAL Tablet-based Session (Tablet Blu)
- BEHAVIORAL Use of Virtual Reality Head Mounted Display without Content (VR Blank)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-05 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT04356963 record still lists
NCT04356963 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Virtual Reality Session (VR Blu) is the first listed.
NCT04356963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04356963 about?
NCT04356963 is a clinical study titled "Adjunct VR Pain Management in Acute Brain Injury". Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. Th...
What is the current status of trial NCT04356963?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-09-05. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT04356963?
The interventions under investigation include: Virtual Reality Session (VR Blu) (BEHAVIORAL), Tablet-based Session (Tablet Blu) (BEHAVIORAL), Use of Virtual Reality Head Mounted Display without Content (VR Blank) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04356963?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04356963's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI